Aptevo Therapeutics (APVO) shares slumped nearly 34% in recent trading Thursday after the company announced the exercise of its warrants at a discount.
Holders of the company's previously issued warrants agreed to exercise the securities for 823,544 shares at $7.50 apiece, netting Aptevo $6.2 million in gross proceeds.
Aptevo will also issue new warrants to the investors to buy up to 1,647,088 shares at an exercise price of $9.53, it said.
Aptevo said it will use the funds for working capital and general corporate purposes. The offering is expected to close by Friday.
Price: 6.65, Change: -3.36, Percent Change: -33.57
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments